DLL4 and atherosclerosis: In a study of Ldlr−/− mice, blocking DLL4-Notch signaling using an anti-DLL4 mAb decreased macrophage accumulation, insulin resistance, and plaque calcification and inhibited the progression of atherosclerosis [191].